Cogent Biosciences reports 65% response rate in mastocytosis trial

Go back to Cogent Biosciences reports 65% response rate in mastocytosis trial
COGENT (NASDAQ: COGT) Delayed: 35.28 --0 (-0%)
Previous Close $35.28    52 Week High $5.57 
Open $35.28    52 Week Low $2.90 
Day High $35.28    P/E 160.36 
Day Low $35.28    EPS $0.22 
Volume 351